Business Development

Abgent in-licenses selected products to offer our customers a wide variety of options for their proteomic research needs, with a focus on cell signaling, apoptosis, cell cycle regulation, and gene product defects. If you are seeking to commercialize a technology in these areas, contact us for further information and non-disclosure agreements. Our experienced discovery and production teams will work with you to jointly evaluate proposals and identify partnering opportunities.